🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The goal of this clinical trial is to learn whether the antibiotic ceftoloz...
Status
Terminated
Location
Weill Cornell Medicine
Start Date
2023-01-10
Trial ID
NCT04673175
Treatments Being Tested
Cervix carcinoma has been a serious, long-term issue in the Czech Republic....
Status
Completed
Location
Aeskulab Patologie, ks
Start Date
2017-09-01
Trial ID
NCT05578833
Patients hospitalized for COVID-19 may need intensive care (e.g. mechanical...
Status
Unknown
Location
LESCURE
Start Date
2020-12-04
Trial ID
NCT04669938
Treatments Being Tested
Background: Hypertriglyceridemia-associated acute pancreatitis (HTG-AP) has...
Status
Recruiting
Location
Department of Gastroenterology, Zhongshan Hospital, Xiamen University
Start Date
2026-01-18
Trial ID
NCT07720232
Introduction Cervical intraepithelial neoplasia CIN1 (low grade), CIN2 (mod...
Status
Unknown
Location
Department of Gynecology and Obstetrics, Herning Regional Hospital
Start Date
2020-06-01
Trial ID
NCT05049252
RATIONALE: Monoclonal antibodies, such as bevacizumab, can block tumor grow...
Status
Unknown
Location
Memorial Sloan-Kettering Cancer Center
Start Date
2006-07
Trial ID
NCT00436709
The goal of this clinical trial is to evaluate the safety, tolerability, ph...
Status
Recruiting
Location
The First Affiliated Hospital, School of Medicine, Zhejiang University
Start Date
2024-11-03
Trial ID
NCT07014449
Treatments Being Tested
RATIONALE: Erlotinib may stop the growth of tumor cells by blocking some of...
Status
Completed
Location
University Hospitals Cleveland Medical Center, Case Comprehensive Cancer Center
Start Date
2007-11-19
Trial ID
NCT00720304
Treatments Being Tested
In this study, investigators utilize a radiopathomics integrated Artificial...
Status
Unknown
Location
Gastrointestinal Department of First Affiliated Hospital of Zhejiang University
Start Date
2024-07-01
Trial ID
NCT06396143
RATIONALE: ABT-510 may stop the growth of melanoma by blocking blood flow t...
Status
Completed
Location
Multiple Locations
Start Date
2004-11
Trial ID
NCT00602199